AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Ophthalmic Multimodal AI-Assisted Medical Decision-Making

Recruitingn/aAges any - anyAllThe Eye Hospital of Wenzhou Medical University
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

This is a multi-center, retrospective clinical study designed to evaluate the application and effectiveness of an AI-assisted medical decision support system, leveraging multimodal data fusion, in ophthalmic clinical practice.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: 1.All patients who have received treatment at multiple centers, including The Eye Hospital of Wenzhou Medical University, First Affiliated Hospital of Wenzhou Medical University, Second Affiliated Hospital of Wenzhou Medical University, ZhuHai Hospital, and Macau University of Science and Technology Hospital. 2.Availability of comprehensive electronic health records (EHR), including: Ophthalmic images (e.g., fundus photography, OCT, or slit-lamp images). Electronic medical records (e.g., diagnosis, treatment, and follow-up notes). Examination results (e.g., visual acuity, intraocular pressure, or laboratory tests). 3.Patients with a clear and confirmed diagnosis of one or more ocular diseases. 4.Patients with sufficient follow-up records to allow assessment of disease progression or prognosis, if applicable. 1. All ophthalmology patients who have previously received treatment at the Department of Ophthalmology, the Eye Hospital of Wenzhou Medical University, First Affiliated Hospital of Wenzhou Medical University, Second Affiliated Hospital of Wenzhou Medical University, Zhuhai People's Hospital, and the University Hospital. 2. Availability of comprehensive electronic health records (EHR), including: Ophthalmic images (e.g., fundus photography, OCT, or slit-lamp images). Electronic medical records (e.g., diagnosis, treatment, and follow-up notes). Examination results (e.g., visual acuity, intraocular pressure, or laboratory tests). 3. Patients with a clear and confirmed diagnosis of one or more ocular diseases. 4. Patients with sufficient follow-up records to allow assessment of disease progression or prognosis, if applicable. Exclusion Criteria: 1. Incomplete or missing critical EHR components. 2. Cases with ambiguous or unverified diagnoses that cannot be clearly categorized. 3. Duplicated or redundant data from the same patient.
๐Ÿ’Š

What it tests

  • Diagnostic Test: AI-Based Diagnostic and Prognostic Model for Ocular Diseases
๐Ÿ“

Where

5 sites
ZhuHai Hospital, zhuhai, guangdong
Zhuhai, China
First Affiliated Hospital of Wenzhou Medical University
Wenzhou, China
Second Affiliated Hospital of Wenzhou Medical Universit
Wenzhou, China
The Eye Hospital of Wenzhou Medical University
Wenzhou, China
Macau University of Science and Technology Hospital
Macao, Macau
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy